Ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block for shoulder arthroscopy pain
Postoperative Analgesic Efficacy of Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery
This will test whether an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block reduces pain after arthroscopic shoulder surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Bursa City Hospital Government |
| Locations | 1 site (Bursa) |
| Trial ID | NCT07394673 on ClinicalTrials.gov |
What this trial studies
This interventional study applies an ultrasound-guided serratus posterior superior intercostal plane (SPSIP) block as a regional analgesic technique for patients having arthroscopic shoulder surgery under general anesthesia. Eligible participants receive the SPSIP block in addition to standard perioperative care as part of a multimodal analgesia plan. Postoperative outcomes will be tracked using patient-reported pain scores (NRS), opioid consumption, and usual recovery measures. The study aims to see if adding the SPSIP block improves early postoperative pain control and recovery after shoulder arthroscopy.
Who should consider this trial
Good fit: Adults scheduled for elective arthroscopic shoulder surgery under general anesthesia with ASA physical status I–III who can provide informed consent and meet the inclusion/exclusion criteria are ideal candidates.
Not a fit: Patients who use anticoagulant or antiplatelet drugs, have bleeding disorders, infection at the block site, allergy to local anesthetics, diabetes, significant renal or hepatic impairment, pregnancy/lactation, or cognitive impairment are excluded and unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the SPSIP block could reduce postoperative pain and opioid requirements and improve recovery after arthroscopic shoulder surgery.
How similar studies have performed: The SPSIP block is a novel regional technique described in 2023 with early reports of near-complete sensory blockade of the posterior neck, shoulder, and hemithorax, but clinical outcome data for shoulder arthroscopy remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Classified as American Society of Anesthesiologists (ASA) physical status I-II-III * Scheduled for elective shoulder arthroscopy surgery * Surgery performed under general anesthesia * Provision of written informed consent Exclusion Criteria: * Use of anticoagulant or antiplatelet medications * Presence of bleeding diathesis or coagulation disorders * Known allergy or hypersensitivity to local anesthetics or opioid medications * Infection or history of previous surgery at the planned block site * Alcohol or drug dependence * Cognitive impairment preventing reliable pain assessment using the NRS * Pregnancy or lactation * Diabetes mellitus * Renal or hepatic impairment
Where this trial is running
Bursa
- Bursa City Hospital — Bursa, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Merih Yıldız Eglen, MD — Bursa City Hospital
- Study coordinator: Mursel Ekinci, Assoc prof, MD
- Email: drmurselekinci@gmail.com
- Phone: +905067137596
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.